Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-Muscle Invasive Bladder Neoplasms × apatorsen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuronopathy, Distal Hereditary Motor, Type IIB 1 Neoplasms 1

Interventions

enfortumab vedotin 1 catumaxomab 1 apatorsen 1 Therapeutics 1 Photochemotherapy 1 Paclitaxel 1 Mitomycin 1 Imiquimod 1 Gemcitabine 1 Ethacrynic Acid 1 Bevacizumab 1 BCG Vaccine 1 Antibodies 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00959868 2012-02-13

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

Vancouver Coastal Health

Phase 1 Unknown

Neuronopathy, Distal Hereditary Motor, Type IIB, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡